Managed Account Advisors’s Integra LifeSciences IART Stock Holding History

Managed Account Advisors’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	$5.75M	Sell	208,662 -31,672	-13%	-$844K	﹤0.01%	1359
2015 Q1	$6.06M	Buy	240,334 +5,507	+2%	+$130K	0.01%	1343
2014 Q4	$5.21M	Sell	234,827 -8,022	-3%	-$163K	0.01%	1377
2014 Q3	$4.93M	Buy	242,849 +15,202	+7%	+$303K	0.01%	1382
2014 Q2	$4.38M	Sell	227,647 -19,119	-8%	-$356K	0.01%	1441
2014 Q1	$4.64M	Buy	246,766 +18,202	+8%	+$351K	0.01%	1358
2013 Q4	$4.46M	Buy	228,564 +9,764	+4%	+$179K	0.01%	1347
2013 Q3	$3.6M	Sell	218,800 -8,108	-4%	-$130K	0.01%	1401
2013 Q2	$3.4M	Buy	+226,908	New	+$3.33M	0.01%	1383

Other funds holding IART

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

VNIM

Vaughan Nelson Investment Management Houston, Texas $11.3B AUM 53% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

WHG

Westwood Holdings Group Dallas, Texas $13.7B AUM 21.48% 1-Year Est. Return

EIP

Epoch Investment Partners New York $16.5B AUM 24.3% 1-Year Est. Return

Managed Account Advisors's IART Position: Q2 2015 in Review

Managed Account Advisors reduced its Integra LifeSciences (IART) stake by 13% in Q2 2015, selling an estimated $844K and leaving 208,662 shares worth $5.75M. The position accounts for ﹤0.01% of the portfolio, ranked #1359.

Managed Account Advisors first reported a position in IART in Q2 2013 and has held it in 9 quarters since. The position peaked at $6.06M in Q1 2015. 186 funds tracked by Wall St. Rank hold IART as of Q2 2015.

Managed Account Advisors held 208,662 shares of Integra LifeSciences worth $5.75M as of Q2 2015.
Managed Account Advisors sold 31,672 Integra LifeSciences shares in Q2 2015, an estimated $844K.
Integra LifeSciences made up ﹤0.01% of Managed Account Advisors's portfolio in Q2 2015, its #1359 holding.
Managed Account Advisors first reported a position in Integra LifeSciences in Q2 2013 and has held it in 9 quarters since.
Managed Account Advisors's Integra LifeSciences position peaked at $6.06M in Q1 2015.
186 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2015.

Based on Managed Account Advisors's 13F filing for Q2 2015, filed 14 Aug 2015.